Related Experiment Video

Updated: Aug 7, 2026

Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
14:21

Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking

Published on: August 6, 2013

Monoamine oxidase and tobacco dependence

A Lewis1, J H Miller, R A Lea

  • 1Institute of Environmental Science and Research Ltd., 34 Kenepuru Drive, P.O. Box 50-348, Porirua, Wellington, New Zealand.

Neurotoxicology
|July 25, 2006
PubMed

Insights

Non-nicotine components in tobacco smoke may contribute to tobacco dependence by inhibiting monoamine oxidase (MAO). Further research into MAO

Area of Science:

  • Neuroscience
  • Pharmacology
  • Public Health

Background:

  • Tobacco smoking is a major cause of preventable death globally.
  • The precise molecular mechanisms of tobacco dependence are not fully understood.
  • Nicotine's effect on dopamine pathways is a known factor in addiction.

Purpose of the Study:

  • To review the current understanding of the association between monoamine oxidase (MAO) and tobacco dependence.
  • To explore the role of non-nicotinic tobacco smoke components in addiction.
  • To identify potential new therapeutic targets for smoking cessation.

Main Methods:

  • Literature review of existing research on MAO inhibition and tobacco dependence.
  • Analysis of studies investigating non-nicotinic components of tobacco smoke.
  • Synthesis of evidence linking MAO activity to neurotransmitter alterations in smokers.

Main Results:

  • Evidence suggests non-nicotinic tobacco smoke constituents inhibit MAO.
  • MAO inhibition leads to altered neurotransmitter levels, potentially contributing to dependence.
  • This pathway offers a complementary explanation to nicotine-driven addiction.

Conclusions:

  • Monoamine oxidase (MAO) plays a significant role in tobacco dependence.
  • Targeting MAO could lead to novel pharmacological treatments for smoking cessation.
  • Further research is warranted to fully elucidate the MAO-dependence link.

More Related Videos

Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices10:04

Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices

Published on: October 29, 2012

Related Concept Videos

Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
Drug Dependence01:17

Drug Dependence

Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...